Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee backs bill requiring insurers to cover biomarker testing after patient and clinician testimony
Summary
S-3098, which would require coverage for medically supported biomarker testing by Medicaid and state‑regulated plans, was favorably released after testimony from cancer researchers, survivors and caregivers who said testing guides targeted treatment and can reduce unnecessary procedures.
The Senate Budget and Appropriations Committee on March 17 favorably released S‑3098, a bill that would require health insurers regulated by the state — including Medicaid and the state employee plans — to cover biomarker (precision medicine) testing when such testing is medically supported.
Dr. Amy Franco, director of the Translational Pediatric Thyroid Cancer Research Program at Children’s Hospital of Philadelphia, told the committee that biomarker testing has transformed cancer care by identifying genetic…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
